Gene Express, Inc. accelerates the supply and delivery of molecular
diagnostics to further facilitate the penetration of Personalized Medicine
as a standard practice in healthcare. Gene Express achieves this by
capitalizing upon its well-developed, patented portfolio that focuses on the
incorporation of internal standards into PCR technologies. This technology
allows Gene Express to produce tests of the highest quality and create
commercial products that are globally translatable.
Gene Express develops patented Standardized Mixtures of Internal Standards
known as SMIS™ that can be incorporated into molecular diagnostics tests.
Gene Express currently has its own proprietary panel of molecular diagnostic
tests that are in development. The goal of Gene Express is to make its
proprietary standards ubiquitous in the development of new and existing
relevant tests and in the inclusion on associated platforms. The inclusion
of these standards provides inter and intra test comparability (across
samples, time and users) and absolute quantification of transcript abundance
results (known as gene expression measurement). This accelerates the
development of new tests and of subsequent regulatory (FDA and /or ex-US)
approval of multi-gene diagnostic tests by providing standardized data that
will meet not only FDA guidance but also global regulatory requirements.
For patients with genetically based medical conditions, Gene Express
discovers, validates and commercializes the most reliable molecular
diagnostics tests. Because the tests are supplied with internal quality
control in each measurement, these tests can be easily incorporated into
standard practice and aid physicians in early disease diagnosis,
administration of personalized medicines and monitoring of treatment
response.
For biopharmaceutical and molecular diagnostics companies, contract research
organizations and basic research labs, Gene Express provides access to the
best in class methodology, assays and reagents because they standardize and
validate measurements of gene expression in a way that allows the
development of personalized drugs, companion diagnostics to the new and
existing drugs, and the development of molecular diagnostic tests. This
enables the translation of technological advances of genomics into
innovative reatments.
For clinical lab test sites such as CLIA labs, central and reference labs,
hospital and doctor’s office labs, Gene Express provides the best system for
controlled gene expression measurement. Because it is the only technology
that offers the precision, specificity, reproducibility and internal quality
control demanded by the regulatory agencies and healthcare reimbursement
system, Gene Express’ technology can eliminate the barriers to wide adoption
of molecular diagnostic tests.
|